McDonald’s Corporation (NYSE:MCD) is the third-largest long-term stock investment of the fund manager. Peak6 holds 320,460 shares of the fast-food chain in its equity portfolio, with a market value of $31.23 million. The largest fast-food chain of the United States has struggled to retain its market share for the past several quarters. As a part of its turnaround plan under new CEO, Steve Easterbrook, the restaurant chain has simplified its menu for drive-through outlets and added some new sandwiches to its existing menu. At the same time, the company is planning some new drinks for the upcoming summer season. Considering the fact that the drive-through zones account for 60% of McDonald’s Corporation (NYSE:MCD)’s revenue, the CEO has put special emphasis on improving the customer experience in that area. The shares of the fast-food chain have improved 3.67% year-to-date. Southeastern Asset Management, First Eagle Investment Management, and Renaissance Technologies are among the top investors of McDonald’s Corporation.
Celgene Corporation (NASDAQ:CELG) is the fourth largest long-term position of Peak6 Investments. The fund holds 255,049 shares of the biopharmaceutical compan, with the shares having a market value of $29.40 million. Celgene Corporation (NASDAQ:CELG)’s shares have largely remained steady, with a 1.36% growth year-to-date. The pharmaceutical company reported net sales of $2.06 billion during the first quarter of 2015, which is 20% higher year-over-year. Its adjusted diluted earnings per share also increased, by 29% year-over-year to $1.07. The biotech firm announced the acquisition of Quanticel Pharmaceuticals for $485 million last month. The deal is likely to offer strength to the oncology drug portfolio of the company. Samuel Isaly‘s healthcare fund Orbimed Advisors, as well as Adage Capital Management hold large positions in Celgene Corporation (NASDAQ:CELG).
Insider Monkey tracks hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points and underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. These stocks were able to generate alpha because of their lower risk profile. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month. These stocks were slightly riskier, so their monthly alpha was 80 basis points. These top small-cap picks have returned 141% over the past 32 months, greatly outperforming the market during that time (read the details here).